Urinary 8-Hydroxydeoxyguanosine Excretion as a Non-Invasive Marker of Neutrophil Activation in Animal Models of Inflammatory Bowel Disease

References

• Podalsky DK. Inflammatory bowel disease. N Engl J Med 1991;325:928–35.
   PubMed Web of Science ®Google Scholar
• Harris ML, Schilller HJ, Reilly PM, Donowitz M, Grisham MB, Bulkley GB. Free radicals and other reactive oxygen metabolites in inflammatory bowel disease: cause, consequence or epiphenomenon? Pharmacol Ther 1992;53:375–408.
   PubMed Web of Science ®Google Scholar
• Babbs CF. Oxygen radicals in ulcerative colitis. Free Rad Biol Med. 1994;13:169–81.
   Web of Science ®Google Scholar
• Grisham MB. Oxidants and free radicals in inflammatory bowel disease. Lancet 1994;344:859–61.
   PubMed Web of Science ®Google Scholar
• Halliwell B, Gutteridge JMC Free radicals in biology and medicine. Oxford: Clarendon Press; 1989. p. 543.
   Google Scholar
• Neurath MF, Pettersson S, zum Buschenfelde KHM, Strober W. Local administration of antisense phosphorothioate oligionuceo-tides in the p65 subunit of NF-kB abrogates established experimental colitis in mice. Nature Med 1996;2:998–1004.
   PubMed Web of Science ®Google Scholar
• Pierce JW, Read MA, Ding H, Luscinskas FW, Collins T. Salicylates inhibit I/sB-a phosphorylation, endothelial-leukocyte adhesion molecule expression, and neutrophil transmigration. J Immunol 1996;156:3961–9.
   Google Scholar
• Bergtold DS, Simic MG, Taylor KA, Ward JF, von Sonntag C, Hauber JN. Urine biomarkers for oxidative DNA damage. In: Simic MG, Taylor KA, Ward JF, von Sonntag C, editors. Oxygen radicals in biology and medicine. New York: Plenum Press; 1987. p. 483–9.
   Google Scholar
• Bergtold DS, Berg CD, Simic MG. Urinary biomarkers in radiation therapy of cancer. In: Emerit I, Packer L, Auclair C, editors. Antioxidants in therapy and preventive medicine. New York: Plenum Press; 1990. p. 311–6.
   Google Scholar
• Shigenaga MK, Gimeno CJ, Ames BN. Urinary 8-hydroxy-2′-deoxyguanosine as a biological marker of in vivo oxidative DNA damage. Proc Natl Acad Sci 1989;86: 9697–701.
   Google Scholar
• Fraga CG, Shigenaga MK, Park J-W, Degan P, Ames BN. Oxidative damage to DNA during aging: 8-hydroxy-2′-deoxy-guanosine in rat organ DNA and urine. Proc Natl Acad Sci 1990;87: 4533–7.
   Google Scholar
• Kaneko T, Tahara S, Matsuo M. Non-linear accumulation of 8-hydroxy-2-deoxyguanosine, a marker of oxidized DNA damage, during aging. Mutat Res 1996;316: 277–85.
   Google Scholar
• Leanderson P, Tagesson C. Rapid and sensitive detection of hydroxyl radicals formed by activated neutrophils in the presence of chelated iron: hydroxylation of deoxyguanosine to 8-hydroxydeoxyguanosine. Agents Actions 1992;36:50–7.
   PubMedGoogle Scholar
• Agarwal S, Sohal RS. DNA oxidative damage and life expectancy in houseflies. Proc Natl Acad Sci 1994;91:12332–5.
   PubMed Web of Science ®Google Scholar
• Richter C. Oxidative damage to mitochondrial DNA and its relationship to ageing. Int J Biochem Cell Biol 1995;27:647–53.
   PubMed Web of Science ®Google Scholar
• Sohal RS, Agarwal S, Sohal BH. Oxidative stress and aging in the Mongolian gerbil (meriones unguiculatus). Mech Aging Dev 1995;81:15–25.
   Google Scholar
• Loft S, Fischer-Nielsen A, Jeding IB, Vistisen K, Poulsen HE. 8-Hydroxydeoxy-guanosine as a urinary biomarker of oxidative DNA damage. J Toxicol Environ Health 1993;40:391–404.
   PubMed Web of Science ®Google Scholar
• Dandona P, Thusu K, Cook S, Snyder B, Makowski J, Armstrong D, et al. Oxidative damage to DNA in diabetes mellitus. Lancet 1996;347:444–5.
   PubMed Web of Science ®Google Scholar
• Frenkel K, Karkoszka J, Kim E, Taioli E. Recognition of oxidized DNA bases by sera of patients with inflammatory diseases. Free Rad Biol Med 1993;14:483–94.
   PubMed Web of Science ®Google Scholar
• Lunec J, Herbert K, Blount S, Griffiths HR, Emery P. 8-Hydroxydeoxyguanosine. A marker of oxidative DNA damage in systemic lupus erythematosus. FEBS Lett 1994;348: 131–8.
   Google Scholar
• Simic MG. Urinary biomarkers and the rate of DNA damage in carcinogenesis and anticarcinogenesis. Mutat Res 1992;267: 277–90.
   PubMed Web of Science ®Google Scholar
• Denda A, Endoh T, Nakae D, Konishi Y. Effects of oxidative stress induced by redox-enzyme modulation on rat hepato-carcinogenesis. Toxicol Lett 1995;82:413–7.
   PubMed Web of Science ®Google Scholar
• Brown RK, McBurney A, Lunec J, Kelly FJ. Oxidative damage to DNA in patients with cystic fibrosis. Free Rad Biol Med 1995;18:801–6.
   PubMed Web of Science ®Google Scholar
• Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 1989;96:795–803.
   PubMed Web of Science ®Google Scholar
• Kvietys PR, Perry MA, Gaginella TS, Granger DN. Ethanol enhances leukocyte-endothelial cell interactions in mesenteric venules. Am J Physiol 1990;22:G578–83.
   Google Scholar
• Kim HS, Berstad A. Experimental colitis in animal models. Scand J Gastroenterol 1992;27:529–37.
   PubMed Web of Science ®Google Scholar
• Andersen R, Laerum F, Bay D, Aas K, Halstensen TS, Stordahl A. Experimental colonic inflammation and ulceration. Gastroenterology 1992;27:757–63.
   Google Scholar
• Yamada T, Marshall S, Specian RD, Grisham MB. A comparative analysis of two models of colitis in rats. Gastroenterology 1992;102:1524–34.
   PubMed Web of Science ®Google Scholar
• Okayasa I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gasterenterology 1990;98:694–702.
   PubMed Web of Science ®Google Scholar
• Dieleman LA, Ridwan BU, Tennyson GS, Beagley KW, Bucy RP, Elson CO. Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology 1994;107:1643–52.
   PubMed Web of Science ®Google Scholar
• Cooper HS, Murthy SNS, Shah RS, Sedergran D. Clinicopatho-logic study of dextran sulfate sodium experimental murine colitis. Lab Invest 1993;69:238–49.
   PubMed Web of Science ®Google Scholar
• Romano M, Lesch CA, Meise KS, Veljaca M, Sanchez B, Kraus ER, et al. Increased gastroduodenal concentrations of transforming growth factor alpha in adaptation to aspirin in monkeys and rats. Gastroenterology 1996;110:1448–55.
   PubMed Web of Science ®Google Scholar
• Bradley PB, Priebat DA, Christensen RD, Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 1982;78: 206–9.
   PubMed Web of Science ®Google Scholar
• Kasai H, Nishimura S. Hydroxylation of deoxyguanosine at the C-8 position by ascorbic acid and other reducing agents. Nucleic Acids Res 1984;12:2137–45.
   PubMed Web of Science ®Google Scholar
• Shigenaga MK, Park J-W, Cundy KC, Gimeno CJ, Ames BN. In vivo oxidative DNA damage: measurement of 8-hydroxy-2′-deoxyguanosine in DNA and urine by high-performance liquid chromatography with electrochemical detection. Meth Enzymol 1990;186: 521–30.
   Google Scholar
• Allgayer H, Hofer P, Schmidt M, Bohne P, Kruis W, Gugler R. Superoxide, hydroxyl and fatty acid radical scavenging by aminosalicylates. Direct evaluation with electron spin resonance spectroscopy. Biochem Pharmacol 1992;43:259–62.
   Google Scholar
• Yamada T, Grisham MB. Role of neutrophil-derived oxidants in the pathogenesis of intestinal inflammation. Klin Wochenschr 1992;69:988–94.
   Google Scholar
• Simmonds NJ, Rampton DS. Inflammatory bowel disease—a radical view. Gut 1993;34:865–8.
   PubMed Web of Science ®Google Scholar
• Boughton-Smith NK. Pathological and therapeutic implications for nitric oxide in inflammatory bowel disease. J R Soc Med 1994;87:312–4.
   PubMed Web of Science ®Google Scholar
• Gibson PR. Current concepts in the pathogenesis of Crohn’s disease. J Gastroenterol Hepatol 1990;5:44–65.
   PubMed Web of Science ®Google Scholar
• Nielsen OH, Ahnfelt-Ronne I. Involvement of oxygen-derived free radicals in the pathogenesis of chronic inflammatory bowel disease. Klin Wochenschr 1991;69:995–1000.
   PubMedGoogle Scholar
• MacDonald TT, Murch SH. Aetiology and pathogenesis of chronic inflammatory bowel disease. Baillieres Clin Gastroenterol 1994;8:1–34.
   PubMed Web of Science ®Google Scholar
• Otamiri T, Sjodahl R. Oxygen radicals: their role in selected gastrointestinal disorders. Dig Dis 1991;9:133–41.
   PubMed Web of Science ®Google Scholar
• Vaananen PM, Meddings JB, Wallace JL. Role of oxygen-derived free radicals in indomethacin-induced gastric injury. Am J Physiol 1991;261:G470–5.
   Google Scholar
• Verspaget HW, Mulder TP, van-der-Sluys-Veer A, Pena AS, Lamers CB. Reactive oxygen metabolites and colitis: a disturbed balance between damage and protection. A selective review. Scand J Gastroenterol 1991;Suppl 188:44–51.
   Google Scholar
• Bhaskar L, Ramakrishna BS, Balasubramanian KA. Colonic mucosal antioxidant enzymes and lipid peroxide levels in normal subjects and patients with ulcerative colitis. J Gastroenterol Hepatol 1995;10:140–3.
   Google Scholar
• Mulder TP, Verspaget HW, Janssens AR, de-Bruin PA, Pena AS, Lamers CB. Decrease in two intestinal copper/zinc containing proteins with antioxidant function in inflammatory bowel disease. Gut. 1991;32:1146–50.
   Google Scholar
• Cohen MS, Britigan BE, Pou S, Rosen GM. Application of spin trapping to human phagocytic cells: insight into conditions for formation and limitation of hydroxyl radical. Free Rad Res Commun 1991;1:17–25.
   Google Scholar
• Salim AS. Role of oxygen-derived free radical scavengers in the management of recurrent attacks of ulcerative colitis: a new approach. J Lab Clin Med 1992;119:710–7.
   PubMed Web of Science ®Google Scholar
• Ahnfelt-Ronne I, Nielsen OH, Christensen A, Langholz E, Binder V, Riis P. Clinical evidence supporting the radical scavenger mechanism of 5-aminosalicylic acid. Gastroenterology 1989;98: 1162–9.
   Google Scholar
• Pronai L, Yukinobu I, Lang I, Feher J. The oxygen-centered radicals scavenging activity of sulfasalazine and its metabolites. A direct protection of the bowel. Acta Physiol Hung 1992;80: 317–23.
   PubMedGoogle Scholar
• Delboy H. Mode d’action de la sulfasalazine dans les enterocolopathies inflammatoires chroniques. Therapie 1992;47: 157–9.
   PubMed Web of Science ®Google Scholar
• Gross V, Arndt H, Andus T, Palitzsch KD, Scholmerich J. Free radicals in inflammatory bowel diseases pathophysiology and therapeutic implications. Hepatogastroenterology 1994;41:320–7.
   Google Scholar
• Malizia G, Calabresse A, Cottone M, Raimondo M, Trejdosiewicz LK, Smart CJ, et al. Expression of leukocyte adhesion molecules by mucosal mononuclear phagocytes in inflammatory bowel disease. Gastroenterology 1991;100:150–9.
   PubMed Web of Science ®Google Scholar
• Koizumi M, King N, Lobb R, Benjamin C, Podalsky DK. Expression of vascular adhesion molecules in inflammatory bowel disease. Gastroenterology 1992;103:840–7.
   Google Scholar
• Wallace JL, Higa A, McKnight GW, MacIntyre DE. Prevention and reversal of experimental colitis by a monoclonal antibody which inhibits leukocyte adherence. Inflammation 1992;16:343–54.
   PubMed Web of Science ®Google Scholar
• Wallace JL, Keenan CM. An orally active inhibitor of leukotriene synthesis accelerates healing in a rat model of colitis. Am J Physiol 1990;258:G527–34.
   PubMed Web of Science ®Google Scholar
• Hoshino H, Sugiyama S, Ohara A, Goto H, Tsukamoto Y, Ozawa T. Mechanism and prevention of chronic colonic inflammation with trinitrobenzene sulfonic acid in rats. Clin Exp Pharmacol Physiol 1992;19:717–22.
   PubMed Web of Science ®Google Scholar
• Wallace JL, Le T, Carter L, Appleyard CB, Beck PL. Hapten-induced chronic colitis in the rat: alternatives to trinitrobenzene sulfonic acid. J Pharmacol Toxicol Meth 1995;33:237–9.
   Google Scholar
• Buell MG, Berin MC. Neutrophil-independence of the initiation of colonic injury. Comparison of results from three models of experimental colitis in the rat. Dig Dis Sci 1994;39:2575–88.
   Google Scholar
• Siems WG, Grune T, Werner A, Gerber G, Buntrock P, Schneider W. Protective influence of oxypurinol on the trinitrobenznen sulfonic acid (TNB) model of inflammatory bowel disease in rats. Cell Mol Biol 1992;38:189–99.
   PubMed Web of Science ®Google Scholar
• Yue G, Sun FF, Dunn C, Yin K, Wong PYK. The 21 aminosteroid tirilazad mesylate can ameliorate inflammatory bowel disease in rats. J Pharm Exp Ther 1996;276: 265–70.
   Google Scholar
• Fitzpatrick LR, Bostwick JS, Renzetti M, Pendleton RG, Decktor DL. Anti-inflammatory effects of various drugs on acetic acid induced colitis in the rat. Agents Actions 1990;30: 393–402.
   Google Scholar
• Domek MJ, Iwata F, Blackman EI, Kao J, Baker M, Vidrich A, et al. Anti-neutrophil serum attenuates dextran sulfate sodium-induced colonic damage in the rat. Scand J Gastroenterol 1995; 30:1089–94.
   PubMed Web of Science ®Google Scholar
• Moyana T, Lalonde JM. Carrageenan-induced intestinal injury: possible role of oxygen free radicals. Ann Clin Lab Sci 1991; 21:258–63.
   PubMed Web of Science ®Google Scholar